Lilly weight-loss pill could be FDA-approved by year-end – Reuters

  1. Lilly weight-loss pill could be FDA-approved by year-end  Reuters
  2. EASD 2025: Orforglipron in Focus, the Case for Cardiovascular Benefits, More  BioSpace
  3. Lilly’s Obesity Pill Will Have Far-Reaching Effect, Doctors Say  Bloomberg.com
  4. Daily weight loss pill can help cut body weight by a fifth, trial shows  The Guardian
  5. Orforglipron: the age of ‘magic weight loss pill’ is almost upon us – and Britain may be first in line  British GQ

Continue Reading